{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:41:56Z","timestamp":1765960916952},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:00:00Z","timestamp":1468454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National High Technology Research and Development Program of China 863 program","award":["2011AA02A116"],"award-info":[{"award-number":["2011AA02A116"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s12026-016-8809-7","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T11:25:09Z","timestamp":1468495509000},"page":"1150-1156","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of serum immunoglobulins concentrations and distributions in vitiligo patients"],"prefix":"10.1007","volume":"64","author":[{"given":"Yulong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingju","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,14]]},"reference":[{"issue":"1","key":"8809_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","volume":"168","author":"A Taieb","year":"2013","unstructured":"Taieb A, Alomar A, Bohm M, Dell\u2019anna ML, De Pase A, Eleftheriadou V, et al. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013;168(1):5\u201319. doi: 10.1111\/j.1365-2133.2012.11197.x .","journal-title":"Br J Dermatol"},{"issue":"3","key":"8809_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"65","author":"A Alikhan","year":"2011","unstructured":"Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65(3):473\u201391. doi: 10.1016\/j.jaad.2010.11.061 .","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"8809_CR3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1034\/j.1600-0749.2003.00023.x","volume":"16","author":"K Ongenae","year":"2003","unstructured":"Ongenae K, Van Geel N, Naeyaert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003;16(2):90\u2013100.","journal-title":"Pigment Cell Res"},{"issue":"Suppl 1","key":"8809_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/dth.12009","volume":"25","author":"Y Valle","year":"2012","unstructured":"Valle Y, Lotti TM, Hercogova J, Schwartz RA, Korobko IV. Multidisciplinary approach to R&D in vitiligo, a neglected skin disease. Dermatol Ther. 2012;25(Suppl 1):S1\u20139. doi: 10.1111\/dth.12009 .","journal-title":"Dermatol Ther"},{"issue":"4","key":"8809_CR5","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1590\/S1516-31802005000400006","volume":"123","author":"CD Machadofilho","year":"2005","unstructured":"Machadofilho CD, Almeida FA, Proto RS, Landman G. Vitiligo: analysis of grafting versus curettage alone, using melanocyte morphology and reverse transcriptase polymerase chain reaction for tyrosinase mRNA. Sao Paulo Med J. 2005;123(4):187\u201391. doi: 10.1590\/S1516-31802005000400006 .","journal-title":"Sao Paulo Med J"},{"issue":"4","key":"8809_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2332\/allergolint.11-OA-0303","volume":"60","author":"T Narita","year":"2011","unstructured":"Narita T, Oiso N, Fukai K, Kabashima K, Kawada A, Suzuki T. Generalized vitiligo and associated autoimmune diseases in Japanese patients and their families. Allergol Int. 2011;60(4):505\u20138. doi: 10.2332\/allergolint.11-OA-0303 .","journal-title":"Allergol Int."},{"issue":"6","key":"8809_CR7","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/1523-1747.ep12492607","volume":"97","author":"R Harning","year":"1991","unstructured":"Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Investig Dermatol. 1991;97(6):1078\u201380.","journal-title":"J Investig Dermatol."},{"issue":"1","key":"8809_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1600-0625.2010.01181.x","volume":"20","author":"EH Kemp","year":"2011","unstructured":"Kemp EH, Emhemad S, Akhtar S, Watson PF, Gawkrodger DJ, Weetman AP. Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Exp Dermatol. 2011;20(1):35\u201340. doi: 10.1111\/j.1600-0625.2010.01181.x .","journal-title":"Exp Dermatol"},{"issue":"11","key":"8809_CR9","first-page":"1837","volume":"2","author":"Y Takechi","year":"1996","unstructured":"Takechi Y, Hara I, Naftzger C, Xu Y, Houghton AN. A melanosomal membrane protein is a cell surface target for melanoma therapy. Clin Cancer Res. 1996;2(11):1837\u201342.","journal-title":"Clin Cancer Res"},{"issue":"Suppl","key":"8809_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2005.10.001","volume":"25","author":"T Passeron","year":"2005","unstructured":"Passeron T, Ortonne JP. Physiopathology and genetics of vitiligo. J Autoimmun. 2005;25(Suppl):63\u20138. doi: 10.1016\/j.jaut.2005.10.001 .","journal-title":"J Autoimmun"},{"issue":"1","key":"8809_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1468-3083.2010.03696.x","volume":"25","author":"V Ingordo","year":"2011","unstructured":"Ingordo V, Gentile C, Iannazzone SS, Cusano F, Naldi L. Vitiligo and autoimmunity: an epidemiological study in a representative sample of young Italian males. J Eur Acad Dermatol Venereol. 2011;25(1):105\u20139. doi: 10.1111\/j.1468-3083.2010.03696.x .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"8809_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1365-4632.2010.04665.x","volume":"50","author":"S Uncu","year":"2011","unstructured":"Uncu S, Yayli S, Bahadir S, Okten A, Alpay K. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. Int J Dermatol. 2011;50(2):175\u20139. doi: 10.1111\/j.1365-4632.2010.04665.x .","journal-title":"Int J Dermatol"},{"key":"8809_CR13","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2011.771","author":"Y Liu","year":"2011","unstructured":"Liu Y, Li J. Preferentially immunoglobulin (IgG) subclasses production in primary Sjogren\u2019s syndrome patients. Clin Chem Lab Med. 2011;. doi: 10.1515\/CCLM.2011.771 .","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"8809_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00296-009-1330-8","volume":"30","author":"G Lin","year":"2010","unstructured":"Lin G, Li J. Elevation of serum IgG subclass concentration in patients with rheumatoid arthritis. Rheumatol Int. 2010;30(6):837\u201340. doi: 10.1007\/s00296-009-1330-8 .","journal-title":"Rheumatol Int"},{"issue":"11","key":"8809_CR15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00535-009-0106-y","volume":"44","author":"M Taguchi","year":"2009","unstructured":"Taguchi M, Kihara Y, Nagashio Y, Yamamoto M, Otsuki M, Harada M. Decreased production of immunoglobulin M and A in autoimmune pancreatitis. J Gastroenterol. 2009;44(11):1133\u20139. doi: 10.1007\/s00535-009-0106-y .","journal-title":"J Gastroenterol"},{"issue":"2","key":"8809_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nri1266","volume":"4","author":"JM Woof","year":"2004","unstructured":"Woof JM, Burton DR. Human antibody-Fc receptor interactions illuminated by crystal structures. Nat Rev Immunol. 2004;4(2):89\u201399. doi: 10.1038\/nri1266 .","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8809_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2133.2012.10889.x","volume":"167","author":"SF Rahoma","year":"2012","unstructured":"Rahoma SF, Sandhu HK, McDonagh AJ, Gawkrodger DJ, Weetman AP, Kemp EH. Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients. Br J Dermatol. 2012;167(1):17\u201328. doi: 10.1111\/j.1365-2133.2012.10889.x .","journal-title":"Br J Dermatol"},{"issue":"4","key":"8809_CR18","first-page":"407","volume":"135","author":"MD Njoo","year":"1999","unstructured":"Njoo MD, Das PK, Bos JD, Westerhof W. Association of the Kobner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol. 1999;135(4):407\u201313.","journal-title":"Arch Dermatol"},{"issue":"12","key":"8809_CR19","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/j.1468-3083.2012.04505.x","volume":"26","author":"KM Alghamdi","year":"2012","unstructured":"Alghamdi KM, Kumar A, Taieb A, Ezzedine K. Assessment methods for the evaluation of vitiligo. J Eur Acad Dermatol Venereol. 2012;26(12):1463\u201371. doi: 10.1111\/j.1468-3083.2012.04505.x .","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"8809_CR20","first-page":"97","volume":"23","author":"R Ali","year":"2010","unstructured":"Ali R, Ahsan MS, Azad MA, Ullah MA, Bari W, Islam SN, et al. Immunoglobulin levels of vitiligo patients. Pak J Pharm Sci. 2010;23(1):97\u2013102.","journal-title":"Pak J Pharm Sci."},{"issue":"2","key":"8809_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.imlet.2012.02.008","volume":"143","author":"SS Santana","year":"2012","unstructured":"Santana SS, Silva DA, Vaz LD, Pirovani CP, Barros GB, Lemos EM, et al. Analysis of IgG subclasses (IgG1 and IgG3) to recombinant SAG2A protein from Toxoplasma gondii in sequential serum samples from patients with toxoplasmosis. Immunol Lett. 2012;143(2):193\u2013201. doi: 10.1016\/j.imlet.2012.02.008 .","journal-title":"Immunol Lett"},{"issue":"2","key":"8809_CR22","doi-asserted-by":"publisher","first-page":"e387","DOI":"10.1097\/MD.0000000000000387","volume":"94","author":"H Zhang","year":"2015","unstructured":"Zhang H, Li P, Wu D, Xu D, Hou Y, Wang Q, et al. Serum IgG subclasses in autoimmune diseases. Medicine. 2015;94(2):e387. doi: 10.1097\/MD.0000000000000387 .","journal-title":"Medicine."},{"issue":"10","key":"8809_CR23","doi-asserted-by":"publisher","first-page":"570","DOI":"10.3109\/00207454.2011.596293","volume":"121","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang W, Li J. Evaluation of serum IgG subclass concentrations in myasthenia gravis patients. Int J Neurosci. 2011;121(10):570\u20134. doi: 10.3109\/00207454.2011.596293 .","journal-title":"Int J Neurosci"},{"issue":"4","key":"8809_CR24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10067-010-1671-4","volume":"30","author":"W Wang","year":"2011","unstructured":"Wang W, Li J. Predominance of IgG1 and IgG3 subclasses of autoantibodies to peptidylarginine deiminase 4 in rheumatoid arthritis. Clin Rheumatol. 2011;30(4):563\u20137. doi: 10.1007\/s10067-010-1671-4 .","journal-title":"Clin Rheumatol"},{"issue":"2","key":"8809_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10067-010-1473-8","volume":"30","author":"A Farboud","year":"2011","unstructured":"Farboud A, Choy E. Serological investigation of IgG levels and subclasses in rheumatoid arthritis patients following ingestion of bovine type II collagen: results of a double blind, randomised controlled trial. Clin Rheumatol. 2011;30(2):193\u20139. doi: 10.1007\/s10067-010-1473-8 .","journal-title":"Clin Rheumatol"},{"issue":"16","key":"8809_CR26","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","volume":"113","author":"P Bruhns","year":"2009","unstructured":"Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood. 2009;113(16):3716\u201325. doi: 10.1182\/blood-2008-09-179754 .","journal-title":"Blood"},{"key":"8809_CR27","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520. doi: 10.3389\/fimmu.2014.00520 .","journal-title":"Front Immunol"},{"issue":"2","key":"8809_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.imlet.2014.01.015","volume":"160","author":"R Kapur","year":"2014","unstructured":"Kapur R, Einarsdottir HK, Vidarsson G. IgG-effector functions: \u201cthe good, the bad and the ugly\u201d. Immunol Lett. 2014;160(2):139\u201344. doi: 10.1016\/j.imlet.2014.01.015 .","journal-title":"Immunol Lett"},{"issue":"17","key":"8809_CR29","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1097\/QAD.0b013e32834b348e","volume":"25","author":"NL Yates","year":"2011","unstructured":"Yates NL, Lucas JT, Nolen TL, Vandergrift NA, Soderberg KA, Seaton KE, et al. Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection. Aids. 2011;25(17):2089\u201397. doi: 10.1097\/QAD.0b013e32834b348e .","journal-title":"Aids."},{"issue":"4","key":"8809_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","volume":"39","author":"RC Aalberse","year":"2009","unstructured":"Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy. 2009;39(4):469\u201377. doi: 10.1111\/j.1365-2222.2009.03207.x .","journal-title":"Clin Exp Allergy"},{"issue":"30","key":"8809_CR31","doi-asserted-by":"publisher","first-page":"20740","DOI":"10.1074\/jbc.M114.572404","volume":"289","author":"LE Rayner","year":"2014","unstructured":"Rayner LE, Hui GK, Gor J, Heenan RK, Dalby PA, Perkins SJ. The Fab conformations in the solution structure of human immunoglobulin G4 (IgG4) restrict access to its Fc region: implications for functional activity. J Biol Chem. 2014;289(30):20740\u201356. doi: 10.1074\/jbc.M114.572404 .","journal-title":"J Biol Chem"},{"issue":"4","key":"8809_CR32","doi-asserted-by":"publisher","first-page":"16060","DOI":"10.4238\/2015.December.7.19","volume":"14","author":"MC Zhu","year":"2015","unstructured":"Zhu MC, Liu CG, Wang DX, Zhan Z. Detection of serum anti-melanocyte antibodies and identification of related antigens in patients with vitiligo. Genet Mol Res. 2015;14(4):16060\u201373. doi: 10.4238\/2015.December.7.19 .","journal-title":"Genet Mol Res"},{"issue":"7","key":"8809_CR33","first-page":"1085","volume":"26","author":"MZ Zailaie","year":"2005","unstructured":"Zailaie MZ. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients. Saudi Med J. 2005;26(7):1085\u201391.","journal-title":"Saudi Med J"},{"issue":"3","key":"8809_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jdermsci.2011.03.004","volume":"62","author":"JY Kim","year":"2011","unstructured":"Kim JY, Do JE, Ahn KJ, Noh S, Jee HJ, Oh SH. Detection of melanocyte autoantigens reacting with autoantibodies in vitiligo patients by proteomics. J Dermatol Sci. 2011;62(3):202\u20134. doi: 10.1016\/j.jdermsci.2011.03.004 .","journal-title":"J Dermatol Sci"},{"issue":"6","key":"8809_CR35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/1523-1747.ep12461505","volume":"90","author":"DA Norris","year":"1988","unstructured":"Norris DA, Kissinger RM, Naughton GM, Bystryn JC. Evidence for immunologic mechanisms in human vitiligo: patients\u2019 sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Investig Dermatol. 1988;90(6):783\u20139.","journal-title":"J Investig Dermatol."},{"issue":"6","key":"8809_CR36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/1523-1747.ep12476728","volume":"100","author":"HS Yu","year":"1993","unstructured":"Yu HS, Kao CH, Yu CL. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo. J Investig Dermatol. 1993;100(6):823\u20138.","journal-title":"J Investig Dermatol."},{"issue":"3","key":"8809_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00918084","volume":"12","author":"RE Jordon","year":"1992","unstructured":"Jordon RE, Xia P, Geoghegan WD. Bullous pemphigoid autoantibodies reactive with intracellular basal keratinocyte antigens: studies of subclass distribution and complement activation. J Clin Immunol. 1992;12(3):163\u20139.","journal-title":"J Clin Immunol"},{"issue":"8","key":"8809_CR38","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2815","volume":"10","author":"C Libert","year":"2010","unstructured":"Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol. 2010;10(8):594\u2013604. doi: 10.1038\/nri2815 .","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8809_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015;74(1):14\u20138. doi: 10.1136\/annrheumdis-2013-204907 .","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"8809_CR40","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000371351","volume":"166","author":"VA Oxelius","year":"2015","unstructured":"Oxelius VA, Krueger R, Ahlstedt S, Keil T, Lau S, Wahn U. Innate IgG molecules and innate B cells expressed by immunoglobulin constant heavy G chain (Fcgamma) genetic marker genes are involved in the \u2018allergic march\u2019 of IgE sensitization in children. Int Arch Allergy Immunol. 2015;166(1):25\u20139. doi: 10.1159\/000371351 .","journal-title":"Int Arch Allergy Immunol"},{"issue":"56","key":"8809_CR41","first-page":"35","volume":"11","author":"ME March","year":"2011","unstructured":"March ME, Sleiman PM, Hakonarson H. The genetics of asthma and allergic disorders. Discov Med. 2011;11(56):35\u201345.","journal-title":"Discov Med."}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-016-8809-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12026-016-8809-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-016-8809-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T18:23:43Z","timestamp":1498328623000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12026-016-8809-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,14]]},"references-count":41,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["8809"],"URL":"https:\/\/doi.org\/10.1007\/s12026-016-8809-7","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,14]]}}}